{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:45:25Z","timestamp":1790142325660,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.mehy.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,6,5]],"date-time":"2016-06-05T21:47:56Z","timestamp":1465163276000},"page":"150-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Anabolic androgenic steroid-induced hepatotoxicity"],"prefix":"10.1016","volume":"93","author":[{"given":"Peter","family":"Bond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Llewellyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Van Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9627","key":"10.1016\/j.mehy.2016.06.004_b0005","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/S0140-6736(08)60801-6","article-title":"Use of doping agents, particularly anabolic steroids, in sports and society","volume":"371","author":"Sj\u00f6qvist","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-0620(98)80019-4","article-title":"The cardiac toxicity of anabolic steroids","volume":"41","author":"Sullivan","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.mehy.2016.06.004_b0015","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/archinte.1991.00400100013003","article-title":"Atherogenic effects of anabolic steroids on serum lipid levels: a literature review","volume":"151","author":"Glazer","year":"1991","journal-title":"Arch Internal Med"},{"issue":"5","key":"10.1016\/j.mehy.2016.06.004_b0020","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.mehy.2016.06.004_b0025","first-page":"113","article-title":"Effects of anabolic-androgenic steroids on the pilosebaceous unit","volume":"50","author":"Scott","year":"1992","journal-title":"Cutis; Cutaneous Med. Pract"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006534-200101000-00039","article-title":"Management of gynecomastia due to use of anabolic steroids in bodybuilders","volume":"107","author":"Babigian","year":"2001","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.mehy.2016.06.004_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0676.1992.tb00560.x","article-title":"Liver pathology associated with the use of anabolic-androgenic steroids","volume":"12","author":"See","year":"1992","journal-title":"Liver"},{"key":"10.1016\/j.mehy.2016.06.004_b0040","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1136\/bmj.e468","article-title":"Cholestasis secondary to anabolic steroid use in young men","volume":"344","author":"Elsharkawy","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.mehy.2016.06.004_b0045","first-page":"405","article-title":"Peliosis hepatis. twelve cases associated with oral androgen therapy","volume":"101","author":"Nadell","year":"1977","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1249\/00005768-199401000-00002","article-title":"Peliosis hepatis in a young adult bodybuilder","volume":"26","author":"Cabasso","year":"1994","journal-title":"Med Sci Sports Exercise"},{"issue":"7790","key":"10.1016\/j.mehy.2016.06.004_b0055","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(72)92649-9","article-title":"Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma","volume":"300","author":"Johnson","year":"1972","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0060","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/1097-0142(197710)40:4<1761::AID-CNCR2820400454>3.0.CO;2-C","article-title":"Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone)","volume":"40","author":"Hernandez-Nieto","year":"1977","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.mehy.2016.06.004_b0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/clinchem\/42.7.1001","article-title":"Metabolism of anabolic androgenic steroids","volume":"42","author":"Sch\u00e4nzer","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.mehy.2016.06.004_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-642760-8.50005-3","article-title":"Oxidative stress: introductory remarks","author":"Sies","year":"1985","journal-title":"Oxid Stress"},{"key":"10.1016\/j.mehy.2016.06.004_b0075","first-page":"w13659","article-title":"Reactive oxygen species: from health to disease","volume":"142","author":"Brieger","year":"2012","journal-title":"Swiss Med Weekly"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mehy.2016.06.004_b0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J Physiol"},{"issue":"11","key":"10.1016\/j.mehy.2016.06.004_b0090","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1089\/ars.2009.2695","article-title":"Mitochondrial glutathione, a key survival antioxidant","volume":"11","author":"Mar\u00ed","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mehy.2016.06.004_b0095","first-page":"3","article-title":"Metal-induced hepatotoxicity","volume":"vol. 16","author":"Britton","year":"1996"},{"issue":"9","key":"10.1016\/j.mehy.2016.06.004_b0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00002018-200225090-00003","article-title":"Mechanisms of nsaid-induced hepatotoxicity","volume":"25","author":"Boelsterli","year":"2002","journal-title":"Drug Saf"},{"issue":"11","key":"10.1016\/j.mehy.2016.06.004_b0105","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3109\/10715762.2013.819428","article-title":"Role of oxidative stress in the pathogenesis of alcohol-induced liver disease","volume":"47","author":"Sid","year":"2013","journal-title":"Free Radical Res"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/1570193X113106660025","article-title":"Looking for organ damages due to anabolic-androgenic steroids (aas): is oxidative stress the culprit?","volume":"10","author":"Cerretani","year":"2013","journal-title":"Mini-Rev Org Chem"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/1056-8719(94)00073-D","article-title":"Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures","volume":"33","author":"Welder","year":"1995","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jsbmb.2003.09.001","article-title":"Effects of prolonged stanozolol treatment on antioxidant enzyme activities, oxidative stress markers, and heat shock protein hsp72 levels in rat liver","volume":"87","author":"Pey","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.mehy.2016.06.004_b0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1163\/157075611X616905","article-title":"Changes in the hepatic and renal structure and function after a growth promoter boldenone injection in rabbits","volume":"62","author":"El-Moghazy","year":"2012","journal-title":"Anim Biol-Leiden"},{"issue":"9","key":"10.1016\/j.mehy.2016.06.004_b0130","doi-asserted-by":"crossref","first-page":"e102699","DOI":"10.1371\/journal.pone.0102699","article-title":"The anabolic androgenic steroid nandrolone decanoate disrupts redox homeostasis in liver, heart and kidney of male wistar rats","volume":"9","author":"Frankenfeld","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1593\/neo.06739","article-title":"Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy","volume":"9","author":"Pinthus","year":"2007","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system from concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0145","first-page":"761","article-title":"Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies","volume":"37","author":"Lin","year":"2010","journal-title":"Int J Oncol"},{"issue":"5","key":"10.1016\/j.mehy.2016.06.004_b0150","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0006-2952(91)90088-M","article-title":"Treatment with anabolic steroids increases the activity of the mitochondrial outer carnitine palmitoyltransferase in rat liver and fast-twitch muscle","volume":"41","author":"Guzm\u00e1n","year":"1991","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2016.06.004_b0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1194\/jlr.M028969","article-title":"Differential effects of estrogen\/androgen on the prevention of nonalcoholic fatty liver disease in the male rat","volume":"54","author":"Zhang","year":"2013","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.mehy.2016.06.004_b0160","first-page":"449","article-title":"Ultrastructural changes induced by anabolic steroids in liver of trained rats","volume":"8","author":"Gragera","year":"1993","journal-title":"Histol Histopathol"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1196\/annals.1427.020","article-title":"Structural diversity of mitochondria","volume":"1147","author":"Mannella","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/15563650701590910","article-title":"Multivitamins and phospholipids complex protects the hepatic cells from androgenic-anabolic-steroids-induced toxicity","volume":"46","author":"Pagonis","year":"2008","journal-title":"Clin Toxicol"},{"issue":"3","key":"10.1016\/j.mehy.2016.06.004_b0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0168-8278(97)80361-3","article-title":"Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis","volume":"27","author":"Aleynik","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.mehy.2016.06.004_b0180","first-page":"79","article-title":"[Hepatoprotective effects of silymarin in androgenic-anabolic steroid-induced liver damage]","volume":"56","author":"Radovanovi\u0107","year":"2002","journal-title":"Med Pregl"},{"issue":"3","key":"10.1016\/j.mehy.2016.06.004_b0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J Hepatol"},{"issue":"12","key":"10.1016\/j.mehy.2016.06.004_b0190","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/jcem-24-12-1334","article-title":"Failure of non-17-alkylated anabolic steroids to produce abnormal liver function tests","volume":"24","author":"Marquardt","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mehy.2016.06.004_b0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archinte.1965.03870020129023","article-title":"Methyltestosterone, related steroids, and liver function","volume":"116","author":"Gordan","year":"1965","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mehy.2016.06.004_b0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0026-0495(83)90027-6","article-title":"Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action","volume":"32","author":"Chesnut","year":"1983","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.mehy.2016.06.004_b0205","first-page":"150","article-title":"Oxymetholone for the treatment of hiv-wasting: a double-blind, randomized, placebo-controlled phase iii trial in eugonadal men and women","volume":"4","author":"Hengge","year":"2002","journal-title":"HIV Clin Trials"},{"issue":"04","key":"10.1016\/j.mehy.2016.06.004_b0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-1024704","article-title":"Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders","volume":"12","author":"Kuipers","year":"1991","journal-title":"Int J Sports Med"},{"issue":"6","key":"10.1016\/j.mehy.2016.06.004_b0215","doi-asserted-by":"crossref","first-page":"E1172","DOI":"10.1152\/ajpendo.2001.281.6.E1172","article-title":"Testosterone dose-response relationships in healthy young men","volume":"281","author":"Bhasin","year":"2001","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2125.1983.tb01456.x","article-title":"Drug hepatotoxicity","volume":"15","author":"Timbrell","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0022-4731(87)90317-7","article-title":"Towards the mapping of the progesterone and androgen receptors","volume":"27","author":"Ojasoo","year":"1987","journal-title":"J Steroid Biochem"},{"issue":"5","key":"10.1016\/j.mehy.2016.06.004_b0230","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1110\/ps.051905906","article-title":"Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity","volume":"15","author":"Pereira de J\u0301esus-Tran","year":"2006","journal-title":"Protein Sci"},{"issue":"2","key":"10.1016\/j.mehy.2016.06.004_b0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.steroids.2008.10.016","article-title":"Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities: applied modifications in the steroidal structure","volume":"74","author":"Fragkaki","year":"2009","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0240","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0039-128X(76)90084-2","article-title":"Assay of androgen binding sites by exchange with methyltrienolone (r 1881)","volume":"27","author":"Bonne","year":"1976","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.aca.2008.09.037","article-title":"Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays","volume":"637","author":"Houtman","year":"2009","journal-title":"Anal Chim Acta"},{"issue":"1","key":"10.1016\/j.mehy.2016.06.004_b0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0039-128X(66)90114-0","article-title":"Liver toxicity of a new anabolic agent: methyltrienolone (17\u03b1-methyl-4, 9, 11-estratriene-17\u03b2-ol-3-one)","volume":"8","author":"Kr\u00fcskemper","year":"1966","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.mehy.2016.06.004_b0255","first-page":"397","article-title":"Effect of methandrostenolone on blood lipids and liver function tests","volume":"98","author":"Verdy","year":"1968","journal-title":"Can Med Assoc J"},{"issue":"3","key":"10.1016\/j.mehy.2016.06.004_b0260","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.qai.0000197546.56131.40","article-title":"Oxandrolone in the treatment of hiv-associated weight loss in men: a randomized, double-blind, placebo-controlled study","volume":"41","author":"Grunfeld","year":"2006","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"issue":"5","key":"10.1016\/j.mehy.2016.06.004_b0265","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/cpt1973145862","article-title":"Oxandrolone disposition and metabolism in man","volume":"14","author":"Karim","year":"1972","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mehy.2016.06.004_b0270","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/mend.13.3.0255","article-title":"Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone","volume":"13","author":"Kemppainen","year":"1999","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.mehy.2016.06.004_b0275","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/endo-114-6-2100","article-title":"Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin","volume":"114","author":"Saartok","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.06.004_b0280","first-page":"150","article-title":"Oxymetholone for the treatment of hiv-wasting: a double-blind, randomized, placebo-controlled phase iii trial in eugonadal men and women","volume":"4","author":"Hengge","year":"2003","journal-title":"HIV Clin Trials"},{"issue":"4","key":"10.1016\/j.mehy.2016.06.004_b0285","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5414\/CNP71413","article-title":"Oxymetholone ameliorates insulin sensitivity in maintenance hemodialysis patients: a randomized controlled trial","volume":"71","author":"Aramwit","year":"2009","journal-title":"Clin Nephrol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T18:03:45Z","timestamp":1600711425000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716302158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":57,"alternative-id":["S0306987716302158"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.06.004","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anabolic androgenic steroid-induced hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}